The chart below shows the percentage of a drug company’s total sales, by region, from 2002 to 2006.Summarise the information by selecting and reporting the main features, and make comparisons where relevant.

The bar chart illustrates the proportion of total sales made by a pharmaceutical company in three regions the United States of America, Europe, and Asia between 2002 to 2006.

Overall

, it can be seen from the graph in the five-

year

period, products were sold more in Asia and swelled as compared to the United States of America in 5 years, but exports declined every

year

and they became equal to Europe.

Whereas

in Europe the sales showed some fluctuations after it was downward trajectory in the final

year

. It is conspicuous that the company sold 25% of medical products in 2002 and after that export continuously expanded to 35% in 2004 and reached 40% in 2006. Between 2002 to 2004 , the sale was augmented @5% each

year

except the

year

2005, in that

year

it was 37%.

Furthermore

,

initially

, the company sold 41% products in the United States of America in 2002 and it experienced an abrupt plunge to 6% and touched 35% in 2003.

Further

, it fell dramatically to 27% in 2004, after that it started to expand regularly and attained 30% in 2006. Probing ahead, the entity’s sales did not perform well in 2002 and it sold only 34% in Asia after that

year

it started to steadily increase to 38% in 2004, after that

year

it displayed a significant drop to 30% in 2006, before it was 34% in 2005.